Omeros Net Income 2010-2023 | OMER
Omeros Annual Net Income (Millions of US $) |
|
---|---|
2023 | $-118 |
2022 | $47 |
2021 | $194 |
2020 | $-138 |
2019 | $-84 |
2018 | $-127 |
2017 | $-53 |
2016 | $-67 |
2015 | $-75 |
2014 | $-74 |
2013 | $-40 |
2012 | $-38 |
2011 | $-29 |
2010 | $-29 |
2009 | $-21 |
Omeros Quarterly Net Income (Millions of US $) |
|
---|---|
2023-12-31 | $-9 |
2023-09-30 | $-38 |
2023-06-30 | $-37 |
2023-03-31 | $-34 |
2022-12-31 | $129 |
2022-09-30 | $-17 |
2022-06-30 | $-31 |
2022-03-31 | $-33 |
2021-12-31 | $281 |
2021-09-30 | $-23 |
2021-06-30 | $-29 |
2021-03-31 | $-35 |
2020-12-31 | $-37 |
2020-09-30 | $-38 |
2020-06-30 | $-33 |
2020-03-31 | $-29 |
2019-12-31 | $-29 |
2019-09-30 | $-16 |
2019-06-30 | $-14 |
2019-03-31 | $-24 |
2018-12-31 | $-24 |
2018-09-30 | $-39 |
2018-06-30 | $-34 |
2018-03-31 | $-30 |
2017-12-31 | $-17 |
2017-09-30 | $-7 |
2017-06-30 | $-14 |
2017-03-31 | $-15 |
2016-12-31 | $-20 |
2016-09-30 | $-14 |
2016-06-30 | $-13 |
2016-03-31 | $-21 |
2015-12-31 | $-20 |
2015-09-30 | $-20 |
2015-06-30 | $-17 |
2015-03-31 | $-19 |
2014-12-31 | $-21 |
2014-09-30 | $-18 |
2014-06-30 | $-18 |
2014-03-31 | $-17 |
2013-12-31 | $-2 |
2013-09-30 | $-14 |
2013-06-30 | $-14 |
2013-03-31 | $-10 |
2012-12-31 | $-8 |
2012-09-30 | $-13 |
2012-06-30 | $-9 |
2012-03-31 | $-9 |
2011-12-31 | $-10 |
2011-09-30 | $-7 |
2011-06-30 | $-5 |
2011-03-31 | $-7 |
2010-12-31 | $-7 |
2010-09-30 | $-8 |
2010-06-30 | $-8 |
2010-03-31 | $-7 |
2009-12-31 | $-6 |
2009-09-30 | $-4 |
2009-06-30 | $-6 |
2009-03-31 | $-5 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.183B | $0.000B |
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $183.877B | 24.14 |
Stryker (SYK) | United States | $128.028B | 30.70 |
Boston Scientific (BSX) | United States | $107.805B | 33.58 |
Medtronic (MDT) | Ireland | $106.544B | 15.08 |
EssilorLuxottica (ESLOY) | France | $97.060B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.204B | 0.00 |
Haleon (HLN) | United Kingdom | $38.949B | 30.46 |
ResMed (RMD) | United States | $31.437B | 29.52 |
Terumo (TRUMY) | Japan | $25.223B | 35.62 |
Zimmer Biomet Holdings (ZBH) | United States | $24.713B | 15.91 |
Koninklijke Philips (PHG) | Netherlands | $24.656B | 19.10 |
Baxter (BAX) | United States | $20.501B | 14.95 |
Insulet (PODD) | United States | $12.040B | 63.21 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.549B | 0.00 |
Demant (WILYY) | Denmark | $10.525B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.693B | 22.92 |
BellRing Brands (BRBR) | United States | $7.226B | 38.85 |
Haemonetics (HAE) | United States | $4.670B | 23.88 |
Lantheus Holdings (LNTH) | United States | $4.561B | 11.78 |
Perrigo (PRGO) | Ireland | $4.426B | 12.66 |
GN Store Nord (GNNDY) | Denmark | $4.097B | 26.53 |
Prestige Consumer Healthcare (PBH) | United States | $3.563B | 16.84 |
Envista Holdings (NVST) | United States | $3.382B | 12.86 |
Green Thumb Industries (GTBIF) | United States | $3.229B | 102.33 |
QuidelOrtho (QDEL) | United States | $2.712B | 9.84 |
Neogen (NEOG) | United States | $2.671B | 25.69 |
ICU Medical (ICUI) | United States | $2.386B | 17.80 |
Verano Holdings (VRNOF) | United States | $2.161B | 0.00 |
TG Therapeutics (TGTX) | United States | $2.111B | 683.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.061B | 0.00 |
Owens & Minor (OMI) | United States | $1.895B | 18.19 |
Agios Pharmaceuticals (AGIO) | United States | $1.845B | 0.00 |
Canopy Growth (CGC) | Canada | $1.491B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $1.455B | 48.00 |
InMode (INMD) | Israel | $1.444B | 7.47 |
National Vision Holdings (EYE) | United States | $1.364B | 42.49 |
AdaptHealth (AHCO) | United States | $1.309B | 9.85 |
AtriCure (ATRC) | United States | $1.167B | 0.00 |
Warby Parker (WRBY) | United States | $1.163B | 0.00 |
MacroGenics (MGNX) | United States | $0.925B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.857B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.795B | 0.00 |
Evolus (EOLS) | United States | $0.737B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.676B | 14.65 |
VAREX IMAGING (VREX) | United States | $0.660B | 14.25 |
TerrAscend (TSNDF) | Canada | $0.635B | 0.00 |
Quanterix (QTRX) | United States | $0.617B | 0.00 |
Jin Medical (ZJYL) | China | $0.591B | 0.00 |
Valneva SE (VALN) | France | $0.519B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.503B | 0.00 |
PetIQ (PETQ) | United States | $0.480B | 17.93 |
ZimVie (ZIMV) | United States | $0.414B | 25.33 |
Biote (BTMD) | United States | $0.411B | 3.91 |
OraSure Technologies (OSUR) | United States | $0.405B | 6.70 |
Surmodics (SRDX) | United States | $0.366B | 39.52 |
Zynex (ZYXI) | United States | $0.353B | 47.70 |
Viemed Healthcare (VMD) | United States | $0.318B | 31.50 |
Cerus (CERS) | United States | $0.309B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.263B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.249B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.238B | 14.71 |
Organigram Holdings (OGI) | Canada | $0.219B | 0.00 |
Veru (VERU) | United States | $0.198B | 0.00 |
High Tide (HITI) | Canada | $0.182B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.171B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.166B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.165B | 83.00 |
Quipt Home Medical (QIPT) | United States | $0.153B | 0.00 |
InterCure (INCR) | Israel | $0.133B | 22.46 |
FitLife Brands (FTLF) | United States | $0.128B | 20.55 |
MariMed (MRMD) | United States | $0.122B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.111B | 0.00 |
Fonar (FONR) | United States | $0.100B | 8.55 |
Allurion Technologies (ALUR) | United States | $0.096B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Chimerix (CMRX) | United States | $0.084B | 0.00 |
Safety Shot (SHOT) | United States | $0.075B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.062B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.053B | 3.47 |
Apyx Medical (APYX) | United States | $0.050B | 0.00 |
Bright Green (BGXX) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
United-Guardian (UG) | United States | $0.038B | 14.66 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Flora Growth (FLGC) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.016B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.82 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |